These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Recombinant human erythropoietin shortens the bleeding time and corrects the abnormal platelet aggregation in hemodialysis patients. el-Shahawy MA; Francis R; Akmal M; Massry SG Clin Nephrol; 1994 May; 41(5):308-13. PubMed ID: 8050212 [TBL] [Abstract][Full Text] [Related]
3. Platelet function as an indicator of adequate dialysis. Rabiner SF; Drake RF Kidney Int Suppl; 1975 Jan; (2):144-6. PubMed ID: 1057672 [No Abstract] [Full Text] [Related]
5. Improvement of platelet function by increased frequency of hemodialysis. Lindsay RM; Friesen M; Aronstam A; Andrus F; Clark WF; Linton AL Clin Nephrol; 1978 Aug; 10(2):67-70. PubMed ID: 699401 [No Abstract] [Full Text] [Related]
6. Correction of citrate concentration is necessary in platelet aggregometry studies in uremia. Rylance PB; Gordge MP; Weston MJ Clin Nephrol; 1985 Mar; 23(3):155-6. PubMed ID: 3987105 [No Abstract] [Full Text] [Related]
7. Citrate: a major factor in the toxicity of orally administered aluminum compounds. Molitoris BA; Froment DH; Mackenzie TA; Huffer WH; Alfrey AC Kidney Int; 1989 Dec; 36(6):949-53. PubMed ID: 2689754 [No Abstract] [Full Text] [Related]